Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Understanding Pheochromocytoma Attacks and Managing Symptoms

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by

Imagine experiencing sudden spikes in blood pressure, a racing heartbeat, or intense sweating – symptoms that can feel like an anxiety attack or an urgent medical crisis. For individuals with pheochromocytoma, these episodes are not random; they are caused by a rare tumor on the adrenal glands.

While pheochromocytoma is relatively uncommon, affecting about 2 to 8 people per million annually, its impact on health can be severe if not correctly diagnosed and managed.

[signup]

Understanding Pheochromocytoma Attacks

Pheochromocytoma is a rare type of tumor that forms in the adrenal glands, small triangular-shaped glands located on top of each kidney. The adrenal glands are part of the body's endocrine system and secrete hormones that regulate various physiological body functions, including stress responses, heart rate, and blood pressure. 

The adrenal gland has two main parts: the outer cortex and the inner medulla. 

Most pheochromocytomas are benign (non-cancerous) and develop in the adrenal medulla (33). They are composed of chromaffin cells, which are responsible for making epinephrine and norepinephrine. These hormones are made during the body's stress ("fight-or-flight") response to prepare it to respond to stressful situations. They increase heart rate, elevate blood pressure, mobilize energy stores, and direct blood flow and oxygen to the muscles. 

Pheochromocytomas can push abnormally large amounts of catecholamines into the bloodstream, causing an adrenergic crisis or pheochromocytoma attack. These surges of hormones can occur unpredictably or be triggered by certain factors, including: 

  • Physical exertion or injury
  • Emotional stress
  • Childbirth
  • Anesthesia and surgery
  • Medications, such as certain types of antidepressants (monoamine oxidase inhibitors and tricyclic antidepressants), decongestants, and steroids
  • High-tyramine foods, like red wine, chocolate, and cheese

Common Symptoms of Pheochromocytoma Attacks

The most common symptom of pheochromocytoma is high blood pressure (hypertension). More than 60% of people with pheochromocytoma have constant or episodic hypertension, which is often difficult to control and resistant to treatment. 

A pheochromocytoma attack can cause a hypertensive crisis, which is when blood pressure reaches dangerously high levels (180/120 mmHg or higher), significantly increasing the risk of organ damage and related symptoms, such as:

  • Chest pain
  • Shortness of breath
  • Nausea and vomiting
  • Dizziness
  • Confusion
  • Changes in vision
  • Difficulty speaking
  • Loss of consciousness

Other symptoms that patients can experience during an attack include:

  • Headache
  • Sweating
  • Fast and irregular heartbeat
  • Shaking and tremor
  • Anxiety
  • Abdominal pain
  • Pale skin
  • Diarrhea or constipation

The frequency and severity of pheochromocytomas vary between cases and are often related to tumor size. Some tumors do not make extra adrenaline or noradrenaline, and patients will not experience any symptoms. Others may experience attacks that occur once a month to several times a day. (35, 36

Diagnosis of Pheochromocytoma

Diagnosing pheochromocytoma can be tricky because it is rare, and its symptoms often mimic other more common conditions like hypertension or anxiety disorders. Because of this, it's often missed or misdiagnosed.

The first step in diagnosing pheochromocytoma is recognizing the typical combination of symptoms, which often occur in sudden, intense episodes. 

Once pheochromocytoma is suspected, the next step is to test for elevated levels of catecholamines (adrenaline and noradrenaline) in the blood and urine. One of the following is recommended for initial testing

  • Plasma-Free Metanephrines: This blood test measures the breakdown products of catecholamines (called metanephrines), which are elevated in people with pheochromocytomas.
  • 24-Hour Urine Test: Over the course of a day, urine is collected to measure the levels of catecholamines and metanephrines. 

If lab results reveal high levels of plasma or urinary metanephrines, the next step is to locate the tumor using imaging scans with either computed tomography (CT) or magnetic resonance imaging (MRI). 

Research suggests that up to 35% of pheochromocytomas are linked to inherited genetic conditions. Conditions like multiple endocrine neoplasia type 2 (MEN2), von Hippel-Lindau (VHL) disease, and neurofibromatosis type 1 (NF1) increase the risk of pheochromocytoma. Your doctor may refer you to a genetic counselor for genetic testing to identify mutations in the genes that have been linked to the development of these tumors. (42

If you are diagnosed with pheochromocytoma, you will need to establish care with an endocrinologist to discuss treatment options. A small percentage (10%) of pheochromocytomas are identified as being malignant (cancerous) based on metastasis (spread) to other parts of the body. If you have a malignant tumor, an oncologist will also need to join your care team. 

Management of Pheochromocytoma Attacks

Most pheochromocytomas are unilateral (affecting only one adrenal gland) and benign (22). Surgical removal of the tumor is highly effective, with approximately 90% of patients experiencing resolution of symptoms and normalization of hormone levels after the procedure. 

Before surgery, treatment will focus on mitigating symptoms and preventing pheochromocytoma attacks. 

Lifestyle Modifications

Trigger avoidance can help reduce the frequency of attacks:

  • Diet: Avoid foods that can increase catecholamines in the body. These include tyramine-rich foods (fermented foods, red wine, chocolate, aged meats, and cheese), coffee, tea, bananas, citrus fruits, and vanilla. (42
  • Exercise: Avoid strenuous exercise like heavy lifting, running, or high-intensity workouts, which provokes catecholamine release. Gentle exercises like walking, yoga, and light stretching are safer alternatives until the tumor is managed or removed.
  • Stress Management: Emotional stress can activate the body's fight-or-flight response, leading to a surge of catecholamines. Managing stress through relaxation techniques such as meditation, deep breathing exercises, and mindfulness can help lower the risk of triggering an attack.

Medications

Preoperative medication management reduces surgical mortality rates. A preoperative adrenergic blockage is recommended for one to two weeks before surgery to normalize blood pressure and heart rate and prevent a hypertensive crisis during surgery. This is typically achieved with:

Alpha-Blockers 

These are the first-line pharmaceutical treatment for managing pheochromocytoma symptoms. Examples include phenoxybenzamine, prazosin, and doxazosin. (17

These drugs block alpha-adrenergic receptors, to which catecholamines bind to constrict blood vessels. By blocking these receptors, alpha-blockers relax blood vessels and lower blood pressure. (1

Beta-Blockers

Beta-blockers are used to control rapid heart rate (tachycardia) only after blood pressure has been controlled with alpha-blockers. The use of beta-blockers in the absence of alpha-blockers can lead to hypertensive crisis. Examples include propranolol, metoprolol, and atenolol. (17

Beta-blockers block beta-adrenergic receptors, which catecholamines use to increase heart rate and contract the heart muscle. By blocking these receptors, beta-blockers help slow the heart rate and reduce the force of the heart's contractions, relieving symptoms like palpitations and tachycardia. (5

Catecholamine Synthesis Inhibitors

In some cases, a catecholamine synthesis inhibitor, such as metyrosine, is used to reduce the overall production of catecholamines by the tumor. These medications block the enzyme tyrosine hydroxylase, which plays an important role in catecholamine synthesis. (15

Evidence suggests that metyrosine can reduce urinary metanephrines by 50% and that patients experience better blood pressure control and reduced blood loss during surgery when it is administered with alpha-blockers (15).  

Living with Pheochromocytoma

With appropriate treatment, including surgical removal of the tumor, patients with small, benign pheochromocytoma have a five-year survival rate of 95%. Five-year survival rates decrease to 34-60% in recurrent or malignant pheochromocytoma cases. (33)

Pheochromocytoma recurrence rates range between 6.5% and 16.5%, depending on tumor characteristics and the completeness of surgical removal. Therefore, regular follow-up is an important aspect of pheochromocytoma management. After surgery, patients will require ongoing monitoring at least once a year to assess for recurrence or metastasis. 

Left untreated, pheochromocytoma poses an increased risk for life-threatening complications. Chronic hypertension can cause damage to the arteries, heart, brain, kidneys, and eyes. It raises the risk of cardiovascular disease and life-threatening events, such as heart attack and stroke.

FAQs on Pheochromocytoma Attacks

1. What are the symptoms of a pheochromocytoma attack?

The most common symptoms of a pheochromocytoma attack include:

  • Elevated blood pressure
  • Palpitations (rapid or irregular heartbeat)
  • Headache
  • Sweating
  • Feelings of anxiety or panic

2. What triggers a pheochromocytoma attack?

Common triggers for pheochromocytoma attacks include: 

  • Physical or emotional stress
  • Certain medications 
  • Surgery 
  • Tyramine-rich foods

3. How are pheochromocytoma attacks different from other hypertensive crises? 

Pheochromocytoma attacks are characterized by sudden surges of catecholamines released from the tumor, leading to the rapid onset of symptoms such as palpitations and sweating (34).  

In contrast, other hypertensive crises may result from chronic hypertension or underlying health conditions. Most commonly, it is caused by a failure to take prescribed blood pressure medications. (23)

5. What should I do if I experience a pheochromocytoma attack?

If you experience a pheochromocytoma attack, try to stay calm and find a safe place to sit or lie down. Talk to a doctor as soon as possible to discuss these symptoms. 

Monitor your blood pressure. If your blood pressure is 180/120 mmHg or higher, retake it after 1-2 minutes. Call 911 immediately if the second reading is just as high and you are experiencing any of the following symptoms:

  • Chest pain
  • Shortness of breath
  • Back pain
  • Numbness
  • Muscle weakness
  • Changes in vision
  • Difficulty speaking
  • Vomiting 
  • Dizziness
  • Confusion

[signup]

Key Takeaways

  • Pheochromocytoma is a rare adrenal gland tumor that causes excessive secretion of catecholamines, leading to severe symptoms such as high blood pressure, rapid heart rate, and anxiety – commonly triggered by stress, certain medications, and diet.
  • Long-term management of pheochromocytoma attacks is dependent on symptom recognition, timely diagnosis, and surgical intervention. 
  • Treatment outcomes are improved with preoperative pharmaceutical intervention and lifestyle adjustments to avoid known triggers.
  • If you or someone you know is experiencing symptoms associated with pheochromocytoma, don't hesitate to talk to a healthcare provider about your concerns. Early intervention can significantly improve outcomes and enhance quality of life.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No lab tests!
  1. Alpha-blockers. (2022, January 18). Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/22321-alpha-blockers
  2. Anderson, S. (2022, May 19). 6 Preventable Risk Factors Associated With Heart Attacks. Rupa Health. https://www.rupahealth.com/post/5-things-to-do-after-a-heart-attack
  3. Aygun, N., & Uludag, M. (2020). Pheochromocytoma and paraganglioma: from Epidemiology to Clinical Findings. The Medical Bulletin of Sisli Hospital, 54(2), 159–168. https://doi.org/10.14744/semb.2020.18794
  4. Bartikoski, S. R., & Reschke, D. J. (2021). Pheochromocytoma Crisis in the Emergency Department. Cureus, 13(3), e13683. https://doi.org/10.7759/cureus.13683
  5. Beta blockers. (2022). Cleveland Clinic. https://my.clevelandclinic.org/health/treatments/22318-beta-blockers
  6. Cheng, Y., Ding, N., Wang, L., et al. (2024). A case report on pheochromocytoma mimicking as fulminant myocarditis—a diagnostic challenge. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1326608
  7. chromaffin cell. (2011, February 2). National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chromaffin-cell
  8. Cloyd, J. (2023, April 10). A Functional Medicine Hypertension Protocol. Rupa Health. https://www.rupahealth.com/post/functional-medicine-hypertension-protocol
  9. Cloyd, J. (2023, June 19). A Functional Medicine Post Stroke Protocol: Testing, Therapeutic Diet, and Integrative Therapy Options. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-post-stroke-protocol-testing-supplements-and-integrative-therapy-options
  10. Cloyd, J. (2023, October 2). A Functional Medicine Approach to Stress Management. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-stress-management
  11. Cloyd, J. (2024, June 20). Understanding Heart Palpitations: Causes, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/understanding-heart-palpitations-causes-diagnosis-and-treatment
  12. Cloyd, K. (2023, September 7). Unlocking Hormonal Health: A Comprehensive Guide to Understanding and Choosing the Right Hormonal Testing for Your Patients. Rupa Health. https://www.rupahealth.com/post/unlocking-hormonal-health-a-comprehensive-guide-to-understanding-and-choosing-the-right-hormonal-testing-for-your-patients
  13. Daglis, S. (2024, August 7). Tachycardia: Don't Let Your Heart Run Away with You. Rupa Health. https://www.rupahealth.com/post/tachycardia-dont-let-your-heart-run-away-with-you
  14. Diorio, B. (2022, October 25). How to Balance Adrenaline Levels Naturally. Rupa Health. https://www.rupahealth.com/post/adrenaline
  15. Fang, F., Ding, L., He, Q., et al. (2020). Preoperative Management of Pheochromocytoma and Paraganglioma. Frontiers in Endocrinology, 11. https://doi.org/10.3389/fendo.2020.586795
  16. García, M. I. D. O., Palasí, R., Gómez, R. C., et al. (2019). Surgical and Pharmacological Management of Functioning Pheochromocytoma and Paraganglioma (R. Mariani-Costantini, Ed.). PubMed; Codon Publications. https://www.ncbi.nlm.nih.gov/books/NBK543229/
  17. Garg, M. K., Kharb, S., Brar, K. S., et al. (2011). Medical management of pheochromocytoma: Role of the endocrinologist. Indian Journal of Endocrinology and Metabolism, 15(Suppl4), S329–S336. https://doi.org/10.4103/2230-8210.86976
  18. Genetic Counseling. Cleveland Clinic. https://my.clevelandclinic.org/health/articles/23086-genetic-counseling
  19. Gerow, S. (2024, May 20). Hormones (Types, Definition & Functions). Rupa Health. https://www.rupahealth.com/post/hormones-types-definition-functions
  20. Gil-Barrionuevo, E., Balibrea, J. M., Caubet, E., et al. (2018). Adrenergic cardiomyopathy and cardiogenic shock as initial presentation of pheochromocytoma. A case report and review of the literature. International Journal of Surgery Case Reports, 49, 145–148. https://doi.org/10.1016/j.ijscr.2018.06.024
  21. Gunawardane, P. T. K., & Grossman, A. (2017). Phaeochromocytoma and Paraganglioma. Advances in Experimental Medicine and Biology, 956, 239–259. https://doi.org/10.1007/5584_2016_76
  22. Gupta, P. K., & Marwaha, B. (2023, March 5). Pheochromocytoma. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK589700/
  23. Hypertensive Crisis. (2022, November 22). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/24470-hypertensive-crisis
  24. Jandou, I., Moataz, A., Dakir, M., et al. (2021). Malignant pheochromocytoma: A diagnostic and therapeutic dilemma. International Journal of Surgery Case Reports, 83, 106009. https://doi.org/10.1016/j.ijscr.2021.106009
  25. Kantorovich, V., Eisenhofer, G., & Pacak, K. (2008). PHEOCHROMOCYTOMA: AN ENDOCRINE STRESS MIMICKING DISORDER. Annals of the New York Academy of Sciences, 1148, 462–468. https://doi.org/10.1196/annals.1410.081
  26. Khakham, C. (2023, March 27). An integrative approach to endocrinology. Rupa Health. https://www.rupahealth.com/post/an-integrative-approach-to-endocrinology
  27. Khakham, C. (2023, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs
  28. Kresge, K. (2023, March 21). An Integrative Medicine Team Approach to Treating Anxiety. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-team-approach-to-treating-anxiety
  29. Maholy, N. (2023, April 14). How to reduce stress through mind-body therapies. Rupa Health. https://www.rupahealth.com/post/how-to-reduce-stress-through-mind-body-therapies
  30. Malani, S. (2023, March 8). What is Integrative Oncology and How Can it Help Your Cancer Journey? Rupa Health. https://www.rupahealth.com/post/what-is-integrative-oncology-and-how-can-it-help-your-cancer-journey
  31. Multiple endocrine neoplasia, type 2 (MEN 2). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/men-2/symptoms-causes/syc-20540486
  32. Neurofibromatosis type 1. (2024, September 10). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/neurofibromatosis-type-1/symptoms-causes/syc-20350490
  33. Pheochromocytoma. (2020, February 12). National Cancer Institute. https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/pheochromocytoma
  34. Pheochromocytoma. (2020, March 3). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/pheochromocytoma/symptoms-causes/syc-20355367
  35. Pheochromocytoma. (2022, June 30). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/23373-pheochromocytoma
  36. Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Patient Version. (2011, December 23). National Cancer Institute. https://www.cancer.gov/types/pheochromocytoma/patient/pheochromocytoma-treatment-pdq
  37. Sweetnich, J. (2023, February 28). How to Balance Cortisol Levels Naturally. Rupa Health. https://www.rupahealth.com/post/how-to-balance-cortisol-levels-naturally
  38. Sweetnich, J. (2023, June 12). Integrative Treatment Options for Adrenal Disorders: Specialty Testing, Nutrition, Supplements. Rupa Health. https://www.rupahealth.com/post/integrative-treatment-options-for-adrenal-disorders-specialty-testing-nutrition-supplements
  39. Telenius-Berg, M., Adolfsson, L., Berg, B., et al. (2017). Catecholamine release after physical exercise. A new provocative test for early diagnosis of pheochromocytoma in multiple endocrine neoplasia type 2. Acta Medica Scandinavica, 222(4), 351–359. https://pubmed.ncbi.nlm.nih.gov/2892350/
  40. Venugopal, S., Chhabria, M., & Quartuccio, M. (2020). Recurrence of Pheochromocytoma With Metastases After Resection of Primary Tumor. Cureus, 12(5), e8328. https://doi.org/10.7759/cureus.8328
  41. Von Hippel-Lindau Disease (VHL). National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/disorders/von-hippel-lindau-disease-vhl
  42. Weinberg, J. L. (2024, January 25). A Functional Medicine Approach to Pheochromocytoma. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-pheochromocytoma
  43. What are common symptoms of pheochromocytoma? Eunice Kennedy Shriver National Institute of Child Health and Human Development. https://www.nichd.nih.gov/health/topics/pheochrom/conditioninfo/symptoms
  44. When To Call 911 About High Blood Pressure. (2017). American Heart Association. https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/hypertensive-crisis-when-you-should-call-911-for-high-blood-pressure
  45. Whitelaw, B. C., Mustafa, O. G., & Prague, J. K. (2019). Pheochromocytoma and Paraganglioma. New England Journal of Medicine, 381(19), 1882–1883. https://doi.org/10.1056/nejmc1912022
  46. Yoshimura, H. (2024, February 27). Strategies for Managing Resistant Hypertension. Rupa Health. https://www.rupahealth.com/post/strategies-for-managing-resistant-hypertension
  47. Yoshimura, H. (2024, March 11). Primary Aldosteronism: Pathophysiology, Diagnosis, and Management. Rupa Health. https://www.rupahealth.com/post/primary-aldosteronism-pathophysiology-diagnosis-and-management
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
National Library of Medicine
Government Authority
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
National Cancer Institute
Government Authority
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source